NO20053689L - Fremgangsmate for fremstilling av quinazolin alkaloider. - Google Patents

Fremgangsmate for fremstilling av quinazolin alkaloider.

Info

Publication number
NO20053689L
NO20053689L NO20053689A NO20053689A NO20053689L NO 20053689 L NO20053689 L NO 20053689L NO 20053689 A NO20053689 A NO 20053689A NO 20053689 A NO20053689 A NO 20053689A NO 20053689 L NO20053689 L NO 20053689L
Authority
NO
Norway
Prior art keywords
compound
preparation
iii
preparing
formula
Prior art date
Application number
NO20053689A
Other languages
English (en)
Norwegian (no)
Inventor
Hans-Rainer Hoffmann
Rudolf Matusch
Joachim Moormann
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32747532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053689(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20053689L publication Critical patent/NO20053689L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
NO20053689A 2003-02-03 2005-07-29 Fremgangsmate for fremstilling av quinazolin alkaloider. NO20053689L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10304141A DE10304141B4 (de) 2003-02-03 2003-02-03 Verfahren zur Herstellung von Chinazolin-Alkaloiden
PCT/EP2004/000485 WO2004069836A1 (de) 2003-02-03 2004-01-22 Verfahren zur herstellung von chinazolin-alkaloiden

Publications (1)

Publication Number Publication Date
NO20053689L true NO20053689L (no) 2005-07-29

Family

ID=32747532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053689A NO20053689L (no) 2003-02-03 2005-07-29 Fremgangsmate for fremstilling av quinazolin alkaloider.

Country Status (25)

Country Link
US (1) US7495096B2 (pt)
EP (1) EP1590351B1 (pt)
JP (1) JP2006516578A (pt)
KR (1) KR20050096165A (pt)
CN (1) CN100558727C (pt)
AR (1) AR042946A1 (pt)
AT (1) ATE407135T1 (pt)
AU (1) AU2004208873B2 (pt)
BR (1) BRPI0407012A (pt)
CA (1) CA2514945A1 (pt)
DE (2) DE10304141B4 (pt)
DK (1) DK1590351T3 (pt)
EA (1) EA009047B1 (pt)
ES (1) ES2314366T3 (pt)
MX (1) MXPA05008179A (pt)
MY (1) MY141734A (pt)
NO (1) NO20053689L (pt)
NZ (1) NZ541101A (pt)
PL (1) PL378406A1 (pt)
PT (1) PT1590351E (pt)
SI (1) SI1590351T1 (pt)
TW (1) TW200418811A (pt)
UA (1) UA81287C2 (pt)
WO (1) WO2004069836A1 (pt)
ZA (1) ZA200505160B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004048927A1 (de) * 2004-10-06 2006-04-20 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Kombination enthaltend Desoxypeganin und Cyp2D6 Inhibitoren
BR112020001698A2 (pt) 2017-08-03 2020-07-21 Galectin Sciences, Llc compostos para prevenção e tratamento de distúrbios médicos e usos dos mesmos
KR102728780B1 (ko) * 2021-11-30 2024-11-08 이화여자대학교 산학협력단 데옥시바시시논을 유효성분으로 포함하는 미백용 조성물 및 상기 데옥시바시시논 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU605614A1 (ru) * 1971-10-20 1978-05-05 Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср Антихолинэстеразное средство
JP3180464B2 (ja) * 1991-08-30 2001-06-25 新日本理化株式会社 ジアセタール化合物の製造方法
DE19530606A1 (de) * 1995-08-21 1997-02-27 Basf Ag 1-(Pyridyl)-pyrazole
JP3958452B2 (ja) * 1997-10-31 2007-08-15 大日精化工業株式会社 新規化学発光試薬及びその製造方法
DE19906979B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906978B4 (de) 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906975B4 (de) 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz

Also Published As

Publication number Publication date
MY141734A (en) 2010-06-15
EA009047B1 (ru) 2007-10-26
AR042946A1 (es) 2005-07-06
JP2006516578A (ja) 2006-07-06
PL378406A1 (pl) 2006-04-03
BRPI0407012A (pt) 2006-01-10
TW200418811A (en) 2004-10-01
ZA200505160B (en) 2007-01-31
US20060084669A1 (en) 2006-04-20
KR20050096165A (ko) 2005-10-05
CA2514945A1 (en) 2004-08-19
ES2314366T3 (es) 2009-03-16
DE10304141B4 (de) 2006-03-09
UA81287C2 (en) 2007-12-25
PT1590351E (pt) 2008-11-21
CN1745084A (zh) 2006-03-08
AU2004208873A1 (en) 2004-08-19
EP1590351A1 (de) 2005-11-02
WO2004069836A1 (de) 2004-08-19
NZ541101A (en) 2009-03-31
SI1590351T1 (sl) 2009-02-28
MXPA05008179A (es) 2006-02-17
DE502004007980D1 (de) 2008-10-16
US7495096B2 (en) 2009-02-24
ATE407135T1 (de) 2008-09-15
CN100558727C (zh) 2009-11-11
EA200501135A1 (ru) 2006-02-24
DK1590351T3 (da) 2008-12-15
DE10304141A1 (de) 2004-08-26
HK1075898A1 (zh) 2005-12-30
EP1590351B1 (de) 2008-09-03
AU2004208873B2 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
MX2009003698A (es) Preparacion de azoxistrobina.
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
MX2007004215A (es) Proceso para la sintesis de 4-(3-metansulfonilfenil)-1-n- propilpiperidina.
WO2006021213A3 (en) Vasopressin v1a antagonists
TW200736258A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
WO2008096231A8 (en) Antiparasitic agents
UA99447C2 (ru) Способ получения силденафила
WO2008035212A3 (en) Processes for preparing intermediate compounds useful for the preparation of cinacalcet
NO20063841L (no) Krystallinske polymorfer av en CXC-kjemokinreseptorligand
WO2004002990A3 (en) Synthesis of purine derivatives
IL190040A0 (en) Method for the production of 5-fluoro-1,3-dialkyl-1h-pyrazol-4-carbonyl fluorides
CA2461060A1 (en) Method for preparing pyrimidinone compound and pharmaceutically acceptable salts thereof
WO2005085236A3 (en) Caspase inhibitors and uses thereof
TW200833371A (en) Process for solid formulations
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
NO20053689L (no) Fremgangsmate for fremstilling av quinazolin alkaloider.
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2007123942A3 (en) Benzodioxane and benzodioxolane derivatives and uses thereof
WO2007029084A3 (en) A process for the preparation of carbapenem compounds
AR057555A1 (es) Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
WO2006043175A3 (en) Process for preparing purine compounds
WO2007057767A3 (en) Amino acid derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
RE Reestablishment of rights (par. 72 patents act)
RE Reestablishment of rights (par. 72 patents act)